Maxim Group Targets 175% Gain in Society Pass (SOPA) to $2.75.
If we average out the two most recent price targets this month, we come out with a potential gain of 337% and...
Hidden Gem and a Monster in the Making? Beasley Broadcast Group (BBGI) $0.80
If They Simply Changed Their Name to Beasley Internet Group, it Could be Revalued 3-Fold Higher.
We...
Report: Think Equity Updates Society Pass (SOPA). $6.00 Price Target.
Think Equity: Society Pass (Nasdaq: SOPA) – Path to Profitability
NEW YORK, NY, March 14, 2023 (GLOBE NEWSWIRE) --...
Meet Dennis Nguyen CEO of Start-Up Investor, the Society Pass (Symbol: SOPA)
See a Dazzling Presentation!
Society Pass (SOPA) has quickly acquired 8 companies since going public in late 2021,...
Institutional Analyst: Our #1 Internet Company, Society Pass (Nasdaq: SOPA), Holds Appeal for Both...
Press Release:
February 28, 2023 07:30 ET | Source: Society Pass Incorporated
New York,...
New Report: Society Pass (SOPA), Our #1 Internet Company Trading Under $5.00.
Our #1 Internet Company Trading Under $5.00, Society Pass Holds Appeal for Both Traders and Long-Term Investors.
Dennis Nguyen, Founder/Chairman/CEO of Nasdaq-listed Society Pass Inc. (Nasdaq: SOPA) to Speak at NXT...
SINGAPORE, Feb. 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Society Pass Incorporated ("SoPa”) ( Nasdaq: SOPA ), Southeast Asia’s (SEA) next generation, data-driven, loyalty, fintech and e-commerce...
Private Investor Meetup with Football Star Tim Wright.
Saturday August 6th, Delray Beach
Exclusive cocktail hour with Super Bowl Champion and Dome Audio Founder Tim Wright.
Report: VYRE Network (CAPV).
Update Report: Our First Internet Play in Ages, and It’s a Doozy.
Reporting from the Great City...
VYRE Streaming Network Partners with UNIFD.
With Clients Like McDonald's, Budweiser, CBS Sports, Norton and Intuit-TurboTax, "UNIFD is the Largest Independent Audio & Connected TV Marketplace, Period."
Latest article
Asia-Pacific: A Region of Stability Amidst Economic Uncertainty
Contrary to the Western markets, there is a growing consensus that the Asia Pacific is emerging as a relatively safe harbour in...
Hepion (HEPA) Back in the Spotlight, Gains 230% in May.
Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and...
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating...
A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of...
